Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJuridica Investments Regulatory News (JIL)

  • There is currently no data for JIL

Portfolio Update

31 Aug 2010 07:01

RNS Number : 7859R
Juridica Investments Limited
31 August 2010
 



 

 

 

 

Juridica Investments Limited

('Juridica' or the 'Company')

 

Portfolio Update

 

Juridica, the leading provider of capital to the law market, provides the following portfolio update.

 

The Company is pleased to report that Case 0408-W has reached a successful conclusion which, when the full proceeds have been received, will have delivered a return on investment of 34%. Juridica's portion of the settlement totals US$ 3.8 million having invested US$2.8 million. The Company has already received US$2.4 million and expects the remaining US$1.4 million to be received before 19 January 2011.

 

This positive outcome in the Case occurred despite a negative ruling in Q1 2010 which denied certain of the plaintiff's claims, (as detailed in the Company's Annual Report and Account for 2009). The Company's investment in this claim was structured such that any return over a de minimus amount would generate a return of the Company's investment plus a profit.

 

Commenting on the Case Juridica's Chairman, Lord Brennan, said: "This was one of the Company's initial investments and serves as further validation of our strategy and approach to corporate claims finance. Richard Fields and his team at the investment manager, Juridica Capital Management, continues to show that their due diligence and portfolio monitoring processes provide the best opportunity for our investments to deliver exceptional returns."

 

Juridica will announce its interim results for the six months to 30 June 2010 prior to 30 September 2010.

 

- Ends -

 

 For more information please contact:

 

Juridica Capital Management Limited

Richard Fields, Chief Executive

 

 

+1 866 443 1080

Cenkos Securities plc

(Nominated Adviser and Broker)

Nicholas Wells

Camilla Hume

 

 

+44 20 7397 8900

 

Pelham Bell Pottinger

David Rydell

Olly Scott

 

 

+44 (0) 20 7861 3232

 

 

 

About Juridica

 

Juridica is a leading provider of capital to the business community and the legal market. It invests directly and indirectly in a diversified portfolio of commercial claims and disputes. The Company's objective is to be the premier source of value-added and direct financing or large business claims, especially in the United States and the United Kingdom.

 

Our clients are Fortune 1000 companies, FT Global 500 companies, small businesses, inventors, major universities and the leading law firms that represent them. Juridica accepts only cases that have already been carefully vetted and accepted by qualified lawyers, does not invest in speculative cases and accepts only a small fraction of the cases reviewed.

 

The Company focuses exclusively on business-to-business related claim investments. It does not invest in shareholder class actions, personal injury, product liability, or mass tort claims.

 

Juridica was established on 21 December 2007 as a limited liability, closed-ended investment company registered in Guernsey. It has over US$200 million of assets under management and is listed on AIM, a market operated by the London Stock Exchange (AIM: JIL).

 

The Company has appointed Juridica Capital Management Limited as its exclusive investment manager to locate, select and manage direct and indirect investments in cases, claims and disputes.

 

For more information visit Juridica at http://www.juridicainvestments.com 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUKKODNNBKDOFB
Date   Source Headline
11th Sep 20153:26 pmRNSHolding(s) in Company
19th Aug 20157:00 amRNSHalf Year Results
22nd Jun 201511:17 amRNSDirector/PDMR Shareholding
18th Jun 20154:19 pmRNSPortfolio Update
21st Apr 201510:30 amRNSResult of AGM
27th Mar 20157:00 amRNSNotice of AGM
17th Mar 20157:00 amRNSFinal Results
28th Jan 20153:23 pmRNSHolding(s) in Company
24th Nov 20144:23 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
10th Nov 20147:00 amRNSDividend Declaration
5th Nov 20147:00 amRNSInvestment Manager Arrangements
16th Oct 201410:00 amRNSDirector Declaration
22nd Sep 20147:00 amRNSHalf Yearly Report
1st Jul 201412:30 pmRNSTR-1 Notification of Major Interest in Shares
27th Jun 201412:15 pmRNSHolding(s) in Company
26th Jun 20144:45 pmRNSHolding(s) in Company
26th Jun 20143:30 pmRNSTR-1: Notification Of Major Interest In Shares
24th Jun 20142:00 pmRNSPortfolio update
17th Jun 20142:55 pmRNSTR-1 Notification of Major Interest in Shares
1st May 20147:00 amRNSResult of AGM
8th Apr 20143:44 pmRNSAGM Statement
7th Apr 20147:00 amRNSDirector/PDMR Shareholding
31st Mar 20141:15 pmRNSShare buyback
31st Mar 20141:15 pmRNSPortfolio update
21st Mar 20147:00 amRNSAudited Final Results
7th Feb 20147:00 amRNSPortfolio update
20th Dec 201312:30 pmRNSHolding(s) in Company
19th Dec 20133:11 pmRNSHolding(s) in Company
12th Dec 201312:30 pmRNSSale of Treasury shares
4th Dec 20135:15 pmRNSShares held in Treasury
27th Nov 20133:49 pmRNSHolding(s) in Company
14th Nov 20132:00 pmRNSResult of General Meeting
30th Oct 20137:00 amRNSDividend Declaration
15th Oct 20135:00 pmRNSCirc re. Discontinuation Resolution
1st Oct 20137:00 amRNSPortfolio update
1st Oct 20137:00 amRNSChange of Registered Office
17th Sep 20137:00 amRNSUS$2m strategic stake acquisition in ipCreate Inc.
19th Aug 20137:00 amRNSUnaudited half-year results
13th Aug 20137:00 amRNSPortfolio update
4th Jul 20137:00 amRNSPortfolio Update
2nd May 201311:36 amRNSResult of AGM
8th Apr 20137:00 amRNSNotice of AGM
26th Mar 20137:00 amRNSAppointment of Joint Broker
18th Mar 20134:41 pmRNSUpdate re. Annual General Meeting
15th Mar 201311:00 amRNSNotice of AGM
15th Mar 20137:00 amRNSFinal Results
13th Mar 20139:57 amRNSHolding(s) in Company
12th Mar 20135:52 pmRNSHolding(s) in Company
31st Dec 20127:00 amRNSAcquisition of Shares in Investment Manager
13th Nov 20125:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.